SABSW
USDSAB Biotherapeutics Inc. Warrant
$0.025+0.000 (0.000%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$0.025
High
$0.025
Low
$0.025
Volume
0.00M
Company Fundamentals
Industry
Biotechnology
Country
United States
Trading Stats
Exchange
NCM
Currency
USD
52-Week Range
Low $0.025Current $0.025High $0.025
Related News
GlobeNewswire
SAB BIO Reports Full Year 2024 Operating and Financial Results
MIAMI, March 31, 2025 (GLOBE NEWSWIRE) -- SAB BIO (Nasdaq: SABS), ("SAB BIO" or the "Company"), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human anti-thymocyte
View more
Related Stocks
CROX
Crocs Inc.
NASDAQ
Shoe Manufactur...
TTOO
T2 Biosystems Inc.
NASDAQ
Medical/Dental ...
DBGI
Digital Brands Group Inc.
NASDAQ
Clothing/Shoe/A...
TFINP
Triumph Financial Inc. Depositary Shares Each Representing a 1/40th Interest in a Share of 7.125% Series C Fixed-Rate Non-Cumulative Perpetual Preferred Stock
NASDAQ
Major Banks
UCB
United Community Banks Inc.
NASDAQ
Major Banks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.